BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18303060)

  • 1. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ano-genital papillomavirus infections in women].
    Riethmuller D
    Rev Prat; 2006 Nov; 56(17):1893-900. PubMed ID: 17243387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and therapeutic HPV vaccines.
    Monie A; Hung CF; Wu TC
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genital human papillomavirus infection.
    Dunne EF; Markowitz LE
    Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK; Kendrick JE; Alvarez RD
    Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HPV-infection].
    Schmidt-Petruschkat S
    MMW Fortschr Med; 2007 Mar; 149(12):29-31. PubMed ID: 17674887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
    Kjaer SK
    Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.